Compare BBW & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBW | OCGN |
|---|---|---|
| Founded | 1997 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 473.7M | 474.8M |
| IPO Year | 2004 | 2014 |
| Metric | BBW | OCGN |
|---|---|---|
| Price | $24.56 | $1.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $67.71 | $9.75 |
| AVG Volume (30 Days) | 950.5K | ★ 6.7M |
| Earning Date | 05-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.51% | N/A |
| EPS Growth | ★ 5.00 | N/A |
| EPS | ★ 2.16 | N/A |
| Revenue | ★ $357,866,000.00 | N/A |
| Revenue This Year | $5.63 | N/A |
| Revenue Next Year | $4.62 | $1,718.38 |
| P/E Ratio | $11.79 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $25.43 | $0.97 |
| 52 Week High | $74.38 | $2.73 |
| Indicator | BBW | OCGN |
|---|---|---|
| Relative Strength Index (RSI) | 25.68 | 35.90 |
| Support Level | N/A | N/A |
| Resistance Level | $40.16 | $1.93 |
| Average True Range (ATR) | 1.33 | 0.08 |
| MACD | -0.50 | -0.03 |
| Stochastic Oscillator | 0.22 | 20.73 |
Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments: Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, U.K., Ireland, and two e-commerce sites, the international franchising segment includes royalties and product and fixture sales from other international operations under franchise agreements, and the commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").